Importantly, the incidence of SAH in G-CSF-treated rats (7/14 rats, 50%; 7/8 aneurysms, 87.5%) was significantly higher than that in the vehicle-treated group (0/7 rats; 0/3 aneurysms) (Fig. 3E and 3F). The gene discussed is CSF3; the disease is aneurysm.